Literature DB >> 26820553

Synthesis and structure-activity relationship studies of novel 3,9-substituted α-carboline derivatives with high cytotoxic activity against colorectal cancer cells.

Yi-Chien Lin1, Yi-Fong Chen2, Li-Shin Tseng1, Yueh-Hsuan Lee1, Susan L Morris-Natschke3, Sheng-Chu Kuo4, Ning-Sun Yang5, Kuo-Hsiung Lee6, Li-Jiau Huang7.   

Abstract

In our continued focus on 1-benzyl-3-(5-hydroxymethyl-2-furyl)indazole (YC-1) analogs, we synthesized a novel series of 3,9-substituted α-carboline derivatives and evaluated the new compounds for antiproliferactive effects. Structure activity relationships revealed that a COOCH3 or CH2OH group at position-3 and substituted benzyl group at position-9 of the α-carboline nucleus were crucial for maximal activity. The most active compound, 11, showed high levels of cytotoxicity against HL-60, COLO 205, Hep 3B, and H460 cells with IC50 values of 0.3, 0.49, 0.7, and 0.8 μM, respectively. The effect of compound 11 on the cell cycle distribution demonstrated G2/M arrest in COLO 205 cells. Furthermore, mechanistic studies indicated that compound 11 induced apoptosis by activating death receptor and mitochondria dependent apoptotic signaling pathways in COLO 205 cells. The new 3,9-substituted α-carboline derivatives exhibited excellent anti-proliferative activities, and compound 11 can be used as a promising pro-apoptotic agent for future development of new antitumor agents.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antiproliferative activity; Apoptosis; Structure-activity relationships (SARs); YC-1 analogs; α-Carboline derivatives

Mesh:

Substances:

Year:  2016        PMID: 26820553      PMCID: PMC4754133          DOI: 10.1016/j.ejmech.2016.01.004

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  29 in total

1.  Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors.

Authors:  L Kaczmarek; W Peczyńska-Czoch; J Osiadacz; M Mordarski; W A Sokalski; J Boratyński; E Marcinkowska; H Glazman-Kuśnierczyk; C Radzikowski
Journal:  Bioorg Med Chem       Date:  1999-11       Impact factor: 3.641

2.  YC-1, a novel activator of platelet guanylate cyclase.

Authors:  F N Ko; C C Wu; S C Kuo; F Y Lee; C M Teng
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

3.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

Review 4.  Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure.

Authors:  M van Engeland; L J Nieland; F C Ramaekers; B Schutte; C P Reutelingsperger
Journal:  Cytometry       Date:  1998-01-01

5.  Mechanism of YC-1-induced activation of soluble guanylyl cyclase.

Authors:  A Friebe; D Koesling
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

6.  In vitro and in vivo antiplasmodial activity of cryptolepine and related alkaloids from Cryptolepis sanguinolenta.

Authors:  K Cimanga; T De Bruyne; L Pieters; A J Vlietinck; C A Turger
Journal:  J Nat Prod       Date:  1997-07       Impact factor: 4.050

7.  Synthesis and anticancer evaluation of certain indolo[2,3-b]quinoline derivatives.

Authors:  Yeh-Long Chen; Hsien-Ming Hung; Chih-Ming Lu; Kuang-Chieh Li; Cherng-Chyi Tzeng
Journal:  Bioorg Med Chem       Date:  2004-12-15       Impact factor: 3.641

8.  Synthesis of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole analogues as novel antiplatelet agents.

Authors:  F Y Lee; J C Lien; L J Huang; T M Huang; S C Tsai; C M Teng; C C Wu; F C Cheng; S C Kuo
Journal:  J Med Chem       Date:  2001-10-25       Impact factor: 7.446

9.  Synthesis and cytostatic properties of some 6H-Indolo[2, 3-b][1, 8]naphthyridine derivatives.

Authors:  Henryk Mastalarz; Ryszard Jasztold-Howorko; Felicja Rulko; Alain Croisy; Daniele Carrez
Journal:  Arch Pharm (Weinheim)       Date:  2004-08       Impact factor: 3.751

10.  Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway.

Authors:  Tsong-Long Hwang; Hsiu-Wen Hung; Shu-Hui Kao; Che-Ming Teng; Chin-Chung Wu; Samantha Ju-San Cheng
Journal:  Mol Pharmacol       Date:  2003-12       Impact factor: 4.436

View more
  2 in total

1.  Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities.

Authors:  Ji Liu; Tingting Wang; Xinyang Wang; Lin Luo; Jing Guo; Yanfu Peng; Qibing Xu; Jiefei Miao; Yanan Zhang; Yong Ling
Journal:  Medchemcomm       Date:  2017-03-29       Impact factor: 3.597

Review 2.  Comprehensive review of α-carboline alkaloids: Natural products, updated synthesis, and biological activities.

Authors:  Deping Li; Renze Yang; Jun Wu; Bin Zhong; Yan Li
Journal:  Front Chem       Date:  2022-08-26       Impact factor: 5.545

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.